ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Senhwa Announces First Patient Enrolled in Silmitasertib Trial for Severe COVID-19
January 26, 2021Senhwa Biosciences announced that the first patient has enrolled into an investigator-initiated trial (IIT) of its investigational drug, Silmitasertib, as a treatment for hospitalized COVID-19 patients at Banner Health-University Medical Center in ... -
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19
January 22, 2021Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the first patient has enrolled into an investigator-initiated ...
Pharma Sources Insight January 2025
